A plain guide to the facts
TB-500 is a short piece of thymosin beta-4.
Here you will learn what the short piece is, what scientists tested, and why most results don't prove that it helps people.
TB-500 explained: TB-500 copies only a section of its parent protein
A lab makes TB-500 by joining seven amino acids. These tiny units are what the body uses to build proteins. The seven match parts 17 to 23 of thymosin beta-4. Actin supports a cell's form and movement. The larger protein manages when actin is free. Lab records give TB-500 a weight of 889 daltons. At about ~4963 daltons, the full protein has far more lab weight [1]. These figures show size, but they don't predict an effect.
Keep that size difference in mind as you read. Sellers and sports drug reports call the seven-part piece "TB-500." Most work on wounds, heart harm, and strokes used full thymosin beta-4 [5]. Evidence from the larger protein cannot tell you if the fragment works. Each study below names the form that was used.
Thymosin beta-4 is a 43-residue protein; residue means one small protein part. It is present in almost every human cell [5]. Blood cells send the protein toward an injury. There it holds actin until repair cells must move. TB-500 copies only that holding part. The study guide lets you compare both forms without mixing their results.
TB-500 is not the full parent protein
A lab makes TB-500 by joining seven small protein parts. They match parts 17–23 of thymosin beta-4, where the parent protein keeps hold of actin [1]. Scientists and animal doctors study the fragment, but it has no approval as medicine [5]. Most benefit claims come from the complete protein's work rather than tests of the fragment [5].
The TB-500 peptide copies thymosin beta-4's actin grip
The TB-500 peptide repeats the part of thymosin beta-4 that holds loose actin. Researchers used gelsolin-domain-1, a lab tool that kept the parts still for an X-ray. The image showed one full protein holding one actin piece in a 1:1 pair. It showed detail down to 2 Å, or two ten-billionths of a meter [1]. That detail told scientists where contact took place.
TB-500 carries the holding part but lacks the rest of thymosin beta-4. Careful trials in people have not tested whether this fragment can do the full protein's work [5]. When you judge a repair claim, remember that other parts may also matter.
Research sellers provide the fragment as freeze-dried powder. Their directions use germ-free water and cold storage. It may stay whole longer than full thymosin beta-4. Chemicals in the body can damage it, as can another round of freezing and thawing. You can read how the short piece relates to TB-500 here.
What does TB-500 do? TB-500 may copy one repair step
In injury tests, full thymosin beta-4 helped repair cells travel. The same work reported extra small blood vessels, less swelling, fewer dead cells, and lighter scars [5]. Those results span three decades, but they can't settle how the small chain acts in people.
Actin gives a cell its form and helps it crawl into a wound. Thymosin beta-4 holds loose actin until repair cells need it. Skin cells move across a cut, vessel cells bring blood, and young muscle cells mend hurt muscle [5].
A large thymosin beta-4 review arranged the full-protein results [5]. The protein moved repair cells and lowered the count of scar-making cells. It also eased swelling and cell death after harm, while fresh blood vessels formed. Those results led to trials in skin, eyes, and hearts. None has proved equal results from the small chain, the point you need when weighing a claim.
What does TB-500 mean, and where did TB-500 get its name?
Here, TB means thymosin beta-4. In lab and animal work, TB-500 means the short, man-made piece of that protein. The name is used for a product. It does not name the seven parts taken from thymosin beta-4 [1].
What do researchers study with TB-500?
Some scientists give thymosin beta-4 or its actin-gripping part to animals. Other work keeps single cells in lab dishes. The researchers watch wounds, moving cells, new vessels, heart or brain harm, hair roots, swelling, and scars [5]. These are questions under study, not approved uses for you [5].
TB-500 holds actin, but human effects remain unproved
TB-500 carries over thymosin beta-4's part for holding loose actin [1]. In injury tests, the full protein helped repair cells move. It also grew blood vessels, eased swelling, kept more cells alive, and reduced scars [5]. Human trials haven't proved those effects for the seven-part piece [5].
No controlled human trial has tested the short piece
Scientists have not completed a careful human test of the TB-500 seven-part piece [5]. Remember that when you see an ad borrowing findings from full thymosin beta-4.
Full thymosin beta-4 has been tested in people. Phase 1, the first safety stage, put it into the veins of 40 healthy adults. Four groups received 42, 140, 420, or 1260 mg. Some received a placebo, which looked like treatment but contained no drug. Side effects stayed mostly mild or moderate, and each dose was allowed to continue [6]. Dry-eye trials used drops called RGN-259 [7]. Another trial gave thymosin beta-4 after a sudden heart attack [8]. The early heart-attack study was withdrawn before anyone joined [9].
Scientists have studied the larger thymosin beta-4 protein for years. The short TB-500 piece has no human trial of its own. You can't give the two forms equal credit. Read the TB-500 studies in order, then review the known risks and open questions.
User reports do not count as study results
On the TB-500 effects and safety page, rev3 means the notes were checked a third time. Personal stories sit in their own section, away from the study results. You can also see which worries have a source and which questions no trial has answered.